These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Impact of 'targeted' fluconazole prophylaxis for preterm neonates: efficacy of a highly selective approach?
    Author: Martin A, Pappas A, Lulic-Botica M, Natarajan G.
    Journal: J Perinatol; 2012 Jan; 32(1):21-6. PubMed ID: 21760586.
    Abstract:
    OBJECTIVE: The objective of this study was to evaluate the efficacy of targeted intermittent fluconazole prophylaxis (FP) to high-risk preterm (PT) infants. STUDY DESIGN: Observational pre-post cohort study (n=524). Targeted FP (3  mg  kg(-1)) was administered to PT infants (birth weights <1500  g and <6 weeks of age) who received broad-spectrum antibiotics for more than 2 days and had at least one additional risk factor for invasive candidiasis during the antibiotic administration period. RESULT: Invasive candidiasis decreased significantly from 15.3 to 6.2% during the FP period. Duration of parenteral nutrition (15.5 vs 19.2 days), central line (12.7 vs 15.8 days) and necrotizing enterocolitis rates (7 vs 9.5%) were significantly higher in the FP period. FP was administered to 89 (31.3%) infants; the median (range) number of doses was four (1 to 24) and duration was 7 (1 to 38) days. CONCLUSION: In the current study, targeted intermittent FP to a selected population of PT infants was efficacious in reducing the rate of invasive candidiasis, compared with historical controls.
    [Abstract] [Full Text] [Related] [New Search]